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Abstract 
Eicosanoids are the major metabolites of fatty acids and they have pro-inflammatory anti-
inflammatory proprieties, their role and production in solid biological tissue is important due to 
correlation with many kinds of diseases. A simple and rapid liquid extraction method for 
extracting prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) from salmon liver and further 
determination by LC-MS/MS was developed and validated. The optimal combination of 
chloroform, acetonitrile and formic acid was investigated by simplex extraction design. The 
applied criteria for selecting the optimal mixture composition were the visual observation of 
clearness of supernatant after centrifugation, and the strength of signals represented by peak 
areas of extracted ion chromatogram (EIC).  
Adding 500 µL of acetonitrile and 500 µL of chloroform subsequently to 0.3 g of pulverized 
liver sample was found the optimum extraction system. Formic acid dissolved the liver tissue 
and was ruled out. 
The quantitative analysis was carried out using internal standards and the concentrations of 
internal standards are determined by a Doehlert design to keep the response factors constant in 
the analytical range.  After the determination of the endogenous level of PGE2 and LTB4 in the 
working sample the method was submitted to validation. The proposed method exhibited good 
selectivity and linearity over the range (1-50) ng/g for both LTB4 and PGE2 respectively. In 
addition, the endogenous levels for PGE2 (87 ng/g) and LTB4 (101 ng/g) indicate that the system 
linearity could be extended until 137 ng/g and 151 ng/g respectively.  
A full method validation has been performed, the considered validation parameters were: 
selectivity, limit of detection, limit of quantification, linearity, analytical range, precision 
recovery and stability. Also, since a blank sample was not available, the relative limit of 
quantification taking the endogenous level was considered. The method precision for LTB4 
quantification was found 19-20.6% and the recovery ranged between 98.4-104%, the relative 
limit of quantification was found 15.5%. Both PGE2 and LTB4 were found stable at -80C° in a 
solution of acetonitrile:chloroform (1:1)  after 24 hours.   
Suggestions for future working plan were given covering method development improvement.  
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1. Introduction 
1.1. Background 
1.1.1 Fatty Acids and Eicosanoids 
The metabolism of essential long chain polyunsaturated fatty acids (PUFAs) generates lipid 
mediators which have numerous functions in the regulation of cell proliferation, tissue repair, 
coagulation and immunity, they also play an important role in the pathogenesis of various 
diseases [1]. The omega 3 (ω-3) and omega 6 (ω-6) fatty acids are two kinds of PUFAs that 
cannot be synthesized by mammals and consequently they must be obtained from the diet. Thus, 
the effect of different ω-3 and ω-6 fatty acids is becoming important [2]. 
It is important to explain the way of symbolic naming of PUFAs since it is the naming system 
commonly used in scientific literature. 
The symbol name contains the number of carbon atoms, the number of double bounds and the 
position of the first double bound which is labeled as ω or n while the methyl group is numbered 
as carbon one. As an example, linoleic acid (LA) has 18 carbons, two double bonds. The first 
double bound is located between the 6th and 7th carbons from the methyl end, so it is designated 
as n-6 (or ω-6) fatty acid, and the symbol name is 18:2n-6 [1].  
Linoleic and α-linolenic (α-LNA or ALA, 18:3n-3) acids are representative of ω-6 and ω-3 fatty 
acids respectively, and Eicosanoids are known to be their metabolites. First, AA amd ALA 
released from membrane phospholipids by the action of various phospholipases, before LA is 
converted into arachidonic acid (AA, 20:4n-6), while, ALA is converted into eicosapentaenoic 
acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) by enzyme mediated elongation 
and desaturation processes (Figure 1.1). The AA, as shown in Figure 1.2, is the substrate for 
two classes of enzymes, cyclooxygenases (COX), which produce 2-series prostaglandins, 2-
series prostacyclin and 2-series thromboxane, and lipoxygenases (LOX), which catalyze the 
biosynthesis of hydroxyl eicosatetraenoic acids (HETEs) and 4-series leukotrienes, these are 
generally considered as pro-inflammatory eicosanoids. The EPA exhibits a similar metabolism 
to AA, but it is metabolized to 3-series prostaglandins, and thromboxane from COX and 5-
series leukotrienes, hydroxyl eicosapentaenoic acids from LOX, and these are considered as 
anti-inflammatory eicosanoids [1]. 
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The pro-inflammatory derived eicosanoids are positively linked to inflammatory diseases, such 
as arthritis and asthma, non-inflammatory diseases such as Alzheimer, cardiovascular diseases 
and cancer [3]. DHA are mainly converted to D-series resolvins by LOX. Resolvins is a new 
family of lipid mediators which possess both potent anti-inflammatory and immune-regulatory 
properties [1]. 
 
Figure 1.1 The formation of EPA and DHA from ALA [4]. 
SDA is stearidonic acid, ETA is Eicosatetraoisic acid 
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Fig. 1.2 Metabolism of arachidonic acid by the cyclooxygenase and 5-lipoxygenase pathways. 
(*) 5-Lipoxygenase-activating protein [4]. The eicosanoids of interest in this thesis are indicated 
by the red star. 
 
1.1.2 Eicosanoids and the liver 
Prostaglandins and leukotrienes were first isolated from the liver in 1970 [5]. Several in vivo 
and in vitro studies have demonstrated the cytoprotective effect of prostaglandins such as PGE2 
against viral induced hepatic injury. In addition, some researchers have indicated the role of 
some prostaglandins in the stimulation of blood flow in rat liver [5]. 
All liver cells produce eicosanoids (Table 1.1) but Kupffer cells and endothelial cells are 
quantitatively the most important. Kupffer cells produce both prostaglandin and leukotreins. 
The major prostaglandin are PGD2, PGE2, TxA2, while the major leukotreins are LTB4 and 
LTC4. They play a role in protecting the organism from foreign and endogenous compounds.  
The anatomic location of the Kupffer cells lining the hepatic sinusoid allows filtering foreign 
particles, antigens, and endotoxins by releasing cytokine and generating inflammatory response 
while, at the same time, maintaining an appropriate inflammatory response and cytoprotective 
response by releasing PGE2, which has a cytoprotective effect on the adjacent hepatocytes, and 
exerts a negative feedback on cytokine release [5].  
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Endothelial cells produce primarily PGI2, which protects the liver by counteracting 
vasoconstriction, platelet aggregation, and leukocyte adherence. This protects the 
microcirculation of the liver during injury [5]. 
Unfortunately, the involvement of eicosanoids in fish liver functions have not been studied yet. 
Table 1.1 shows the production and action of different eicosanoid by different types of liver 
cells [5]. 
Table 1.1 The production and action of eicosanoids by different types of liver cells*  
 
 
1.2 Eicosanoid analysis 
 
1.2.1 Instrumental techniques 
 
The main challenge of the analysis of PUFA metabolites in cells, tissues and body fluids are: 
the low endogenous concentrations (~pmol/mg to fmol/mg range), the multitude of isomeric 
and isobaric structures, and the risk of in vitro generation during sample pretreatment [6, 7]. 
Eicosanoids are generally analyzed by gas chromatography-mass spectrometry (GC–MS), 
liquid chromatography-mass spectrometry (LC-MS), enzyme immunoassay (EIA) and 
radioimmunoassay (RIA) as shown in Table 1.2. Although EIA is the most widely 
acknowledged methods for estimation of prostaglandins in biological samples, it has certain 
limitations due to its lack of specificity and its inability to determine multiple analytes in a 
single set of analyses. In addition, the levels of prostaglandins might be overestimated due to 
the possible cross reactivity of the antibody with different prostaglandins and the interference 
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of the fatty acid present in the sample matrix, resulting in a reduced selectivity, as well as the 
variability in the quantification of sequential samples [7, 8]. 
Table 1.2 Overview of the number of the application of different instrumental techniques for 
the analysis of eicosanoids in tissues in the last 30 years. 
Tissue type RIA EIA GCMS LC LCMS UPLC 
Brain 3 [10-12] 1 [11] 6 [13-18] 5 [14,19-23] 12 [22-34] 3 [35-37] 
Lung 4 [38-41] 2 [39, 42, 43] 2 [39, 44]  5 [45-48]  
Kidney 2 [49, 50]  1 [52]  2 [51, 52]  
Muscle      1 [53] 
Bone     1 [54]  
Skin 1 [55] 3 [56, 58]  1 [59] 1 [60]  
Liver 2 [61, 62]    4 [25, 33, 63, 64]  
Gonad   2 [65,66]  1 [67]  
Prostate    1 [68] 4 [8, 33, 48, 51]  
Breast 2 [43, 69]      
Colon 1 [70] 4 [71-75]   7 [63, 72, 76-80] 1 [81] 
Corresponding references are given in square brackets  
 
GC–MS provides greater sensitivity and selectivity for eicosanoid analysis, but requires 
chemical derivatization steps that limit its application since the analytical compounds must be 
both volatile and thermally stable in order to perform GC/MS based analyses.  
The rapid progress of liquid-chromatography–electrospray ionization tandem mass 
spectrometry (LC–ESI-MS/MS) and the simplification of sample preparation have facilitated 
the use of this technology for accurate monitoring of eicosanoid metabolites in biological 
samples [7, 8]. In this technique, the LC component separates the eicosanoids based upon 
physical properties and it is followed by the MS component for identification based upon the 
characteristic product ions. Reversed phase chromatography is most commonly used because 
most eicosanoids, which are medium to nonpolar, elute in order of increasing hydrophobicity 
with a hydrophobic stationary phase (e.g., C18). The first step in mass spectrometry analysis is 
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to convert the analyte molecules into gas phase ions. Following ion production, the ions are 
separated by a mass analyzer that measures the mass to charge ratio (m/z) [6]. 
The main difference between analyzer are: 
1. Their mass range limits (the upper limit of the mass of the ion that can be measured).  
2. Acquisition rate (the rate at which the mass analyzer measures scans over a particular 
mass range). 
3. Transmission range (the ratio of the number of ions reaching the detector to the number 
of ions leaving the source). 
4. Mass accuracy (accuracy of the ion mass measurement provided by the mass analyzer).  
5. Resolution (ability of a mass analyzer to yield 50% valley separation between distinct 
signals of two ions). 
In ESI the ionization process occurs by applying a strong electric field, under atmospheric 
pressure, to a liquid passing through a capillary tube. This field induces a charge accumulation 
at the liquid surface located at the end of the capillary which causes droplets that contain an 
excess positive or negative charge to detach from the capillary tip and move toward the mass 
analyzer, then the solvent evaporates by an uncharged gas (e.g. nitrogen) forcing the molecules 
to get closer together which increases the electrostatic and breaking up the droplets, which then 
forming ions in a process that is still not well understood [6]. 
The main advantage of ESI/MS over other MS techniques is that ESI/MS overcomes the 
propensity of many biomolecules to fragment following ionization and enables the formation 
of multiply charged ions. Thus, ESI/MS is critical for the detailed structural analysis of large 
biomolecules like eicosanoids, moreover it is not necessary to chemically modify eicosanoids 
to enhance ionization efficiently when using this technique [6]. 
Ion traps are normally coupled to ESI ionization source for the structural characterization of 
eicosanoids as a mass analyzer, the ion trap uses an oscillating electric field to trap ions. 
Ion trap mass analyzers exhibit high sensitivity and are most strongly characterized by the 
ability to perform multiple stages of mass spectrometry (MSn). Up to 12 stages of tandem mass 
spectrometry (MS12) have been performed using an ion trap, which greatly increases the amount 
of structural information obtainable for a given molecule. 
An overview of the published methods for analysis of eicosanoids in biological tissues revealed 
that the main focus has been on brain, lung, liver and colon (Table 1.2). One important feature 
of the overview presented in Table 1.2 is the scarcity of methods for determining eicosanoids 
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in fish. The majority of studies presented in Table 1.2 are focused on both human and rodents 
[6]. 
 
Figure 1.3 shows an overview of the application of different analytical techniques for the 
analysis of eicosanoids in solid tissue over the last 30 years, LC/MS has become the main 
technique to analyze eicosanoids the last decade due to the multiple improvements introduced 
in that technique, it is also notable that ultra-performance liquid chromatography UPLC has been 
introduced in the last 10 years as possible technique of choice. 
  
 
Figure 1.3 An overview of the application of different analytical techniques for the analysis of 
eicosanoids in solid tissue over the last 30 years. 
 
1.2.2 Chemical structure of eicosanoids and fragmentation patterns 
 
The analyzed eicosanoids in this thesis are PGE2 and LTB4 and their corresponding deuterated 
analogs PGE2-d4 and LTB4-d4. Their chemical structures are shown in Figure 1.4. 
It is worth to mention that PGE2 and LTB4 have two and four double bonds respectively which 
explains the numbers in their abbreviated names [82].        
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Figure 1.4 Chemical structure eicosanoids analyzed in this thesis and their corresponding 
internal standards 
 
The typical ion fragments of the studied eicosanoids in negative mode are shown in Table 1.3. 
The deuterated internal standards, PGE2-d4 (356 Daltons) and LTB4-d4 (340 Daltons), are 
fragmented in a similar fashion [82]. 
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Table 1.3 the parent ion and the ion fragment for PGE2 and LTB4 
Eicosanoid Parent ion m/z Product ions m/z Corresponding 
products 
PGE2/PGE2-d4 351/355 [M*-H] ¯ 333/337 [M-H2O-H] ¯ 
  317/321 [M-2H2O-H] ¯ 
  271/275 [M- 2H2O-CO2-H] ¯ 
LTB4 335/339[M*-H] ¯ 315/319 [M-H2O-H] ¯ 
  299/303 [M-2H2O-H] ¯ 
  273/377 [M-H2O-CO2-H] ¯ 
  195/197 [M-C9H17O-H] ¯ 
*M is the precursor molecule. 
 
1.2.3 Eicosanoids extraction 
 
The first step in eicosanoids analysis involves the collection of biological samples from human 
or animal subjects. These samples can be solid in nature (tissue) or comprise highly complex 
biofluids (e.g., plasma, serum, urine) [9]. In general, the sample-preparation protocol for tissues 
is more labor intensive and complex than for bio-fluids, due to the need for additional disruption 
and homogenization steps of tissues or cells prior to eicosanoids extraction. 
A typical protocol commences with the sample being rapidly flash-frozen in liquid nitrogen, 
prior to storage at very low temperatures (around -80°C). This step helps to inhibit enzymatic 
activity and to reduce the rate of oxidation, peroxidation and hydrolytic degradation of lipids 
containing unsaturated bonds like eicosanoids [9]. 
Strategies for sample clean-up and concentration in eicosanoid analysis range from solid-phase 
extraction (SPE) over liquid extraction (LE) to protein precipitation to simple solvent 
extraction, with SPE being the most frequently used technique, as shown in Table 1.4 [9]. 
SPE is a popular method for eicosanoid analysis since it is easy to perform, fast, and it cleans 
up interfering matrix without the need to increase the temperature or to use external energy. 
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Nevertheless, it has some disadvantages, such as high cost of the cartridges, and the need to use 
of toxic organic solvents with detrimental effects towards humans and the environment [9]. 
Solvents used for LE of eicosanoids include hexane–ethyl acetate, chloroform–ethyl acetate, 2-
propanol–hexane, or methanol–chloroform while protein precipitation is applied in protocols 
for plasma sample clean-up alone or prior to SPE. 
The main advantages of LE are: it is simple and easy to perform; the low cost solvent used as 
well as the apparatus; no need to use external energy or high temperature; short extraction time 
[9]. However, as shown in Table 1.4, LE has been less used for the extraction of eicosanoids 
from solid tissue due to the complexity of the tissues which is reflected in Table 1.4 by the low 
number of published LE methods compared to SPE methods.  
 
Table 1.4: Overview of the extraction methods different instrumental techniques of eicosanoids 
in tissues prior to chromatography based methods. 
 SPE LE 
Number of methods 23  [12, 13, 15, 16, 19, 22, 25-27, 29, 
32, 33, 35, 37, 44-46, 53, 55, 56, 60, 66, 
78] 
10 [14, 22, 30, 36, 54, 68, 
71, 77, 81, 82] 
Corresponding references are given in square brackets  
 
1.3 Thesis objectives 
The main objective of the present master thesis is to develop a liquid extraction method for 
determining PGE2 and LTB4 in fish liver by means of LC-MS/MS. To this aim the following 
task are proposed: 
1- Application of a mixture design to select the optimal solvent combination for extracting PGE2 
and LTB4 from salmon liver samples.  
2- Determination of the optimal concentrations of internal standards, specifically PGE2-d4 and 
LTB4-d4, by using a Doehlert uniform shell design. 
3- Validation of the developed method with emphasis on selectivity, linearity, precision, 
accuracy, limit of detection, limit of quantification, stability and range. 
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2. Selection of the extraction system 
2.1 Mixture design 
Previous studies have shown that the best solvent combination for extracting prostaglandins 
from fish gonads is acetonitrile and chloroform (1:1) [67]. In addition, another study of the 
determination of prostaglandins and leukotrienes in human plasma has suggested the addition 
of formic acid before the extraction step in order to avoid protein precipitation [83].  
However, the optimal combination of these solvents for the extraction of eicosanoid from 
salmon liver needs to be determined. 
A Mixture design of the type simplex lattice design was chosen to identify the optimum 
extraction mixture [84]. The proportion of the selected solvents rather than the amount of the 
used solvents was the main interest. The proportions of the three solvents must sum up to 1 
satisfying the constraint: 
S1 + S2 + S3 = 1.0            (2.1) 
Where S1 is chloroform, S2 is formic acid and S3 is acetonitrile. 
Thus the proportions of solvents must be adjusted to render a total volume of the extraction 
solution of 1000 µL. 
The used simplex lattice designed is presented in Figure 2.1. Simplex lattice design defines the 
optimum mixture by estimating the response surface over the simplex region, this could be done 
by choosing 10 points (A to J) evenly spread over the whole triangle and each point representing 
a particular solvent mixture where the extraction procedure is implemented.  
The points A, H and J in Figure 2.1 involve single solvent (acetonitrile, formic acid and 
chloroform respectively). Point E represents the centroid point (equal proportion of the three 
solvents), and the selected points C, D and I are located along each side of the triangle and 
characterized by equal proportions of two solvents while the interior points of the triangle B, F 
and G are characterized by different mixture of three solvents. 
Table 2.1 describes all the selected points (A, B, C, …, J) with the corresponding volume of 
solvents in microliters (µL).  
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Figure 2.1 selected points for solvent mixture design 
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Table 2.1 Volume of solvents used in connection with the simplex design portrayed in Figure 
2.1   
Acetonitrile Chloroform Formic Experiment 
1000 0 0 A 
660 170 170 B 
500 0 500 C 
500 500 0 D 
330 330 330 E 
170 170 660 F 
170 660 170 G 
0 0 1000 H 
0 500 500 I 
0 1000 0 J 
 
2.2 Experimental 
2.2.1 Reagents. 
Acetonitrile (liquid chromatographic grade, 99.8%) and formic acid (98%) were obtained from 
Sigma-Aldrich (USA). And chloroform (liquid chromatographic grade, 99.8%) was purchased 
from Merck (Germany). Liquid nitrogen and dry ice were provided by Tess (Norway). 
2.2.2 Extraction procedure 
A wild salmon liver sample stored at -80 °C was crushed to fine powder and homogenized as 
follows: a thick and heavy mortar, previously cooled down with liquid nitrogen, was placed in 
a styrofoam box containing 1 kg of dry ice. The dry ice was placed in a layer on the bottom and 
the mortar on top of it, then the liver sample was placed in the mortar and pulverized by using 
a pestle. Liquid nitrogen was added to the sample to keep the sample frozen during the 
pulverization procedure.  
The pulverized sample was homogenized by a spatula and distributed in portions of 300 µg in 
ten plastic tubes and immediately stored at −80 °C until extraction.  
The ten solvent combinations described in Table 2.1 were added to the ten tubes containing 300 
µg of homogenized salmon liver. The tubes were vortex-mixed for 1 min, centrifuged at 6037×g 
for 1 min, the supernatant collected in test tubes using a Pasteur pipet and the extraction 
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procedure repeated on the remaining flocks from the initially extracted tubes. The supernatants 
of the second extraction are pooled with their corresponding initially collected supernatants,  
dried under nitrogen gas, diluted to 100 µL with acetonitrile, centrifuged at 6037×g for 1 min 
and submitted to LC-MS/MS analysis after confirming lack of precipitation visually. 
It must be mentioned that due to the sample limitation, the experiments were performed in 
duplicate. 
 
2.2.3 Liquid chromatography – Mass spectrometry LC/MS 
The LC/MS was an Agilent 1100 series LC/MSD trap, SL model with an electrospray interface 
(ESI), the injection volume was set to be 25 µL and 30 minutes total analysis time. The column 
used was a Zorbax Eclipse-C8 RP 150 mm×4.6 mm, 5µm (Agilent Technologies, Palo Alto, 
CA, USA) kept at 50 °C. The mobile phase operated in isocratic mode was acetonitrile with 
0.1% (v/v) formic acid at a flow rate of at 0.2 mL/min and UV detection at 254 nm. 
Nitrogen was used as nebulizer and drying gas at 350 °C. The ESI source was operated in 
negative ion mode and the ion optics responsible for getting the ions in the ion-trap such as 
capillary exit, skimmer, lens and octapoles voltages were controlled by using the Smart View 
option with a resolution of 13,000 m/z s
−1
. 
Complete system control, data acquisition and processing were done using the ChemStation for 
LC-MSD Trap Software, Version 5.3 from © Agilent Technologies, Inc., 2005. The analytical 
eicosanoids were isolated as [M−H]− ions (M = PGE2 and LTB4) and the characteristic 
fragment ions used for qualification purposes are referred in Table 1.3The monitored transitions 
were : m/z 351→333, 315, 271 for PGE2 and m/z 335→317, 299, 273, 255, 195 for LTB4. The 
summation of the extracted ion chromatogram (EIC) intensities of the characteristic fragments, 
in ion counts per second, were computed for quantification purposes. 
 
2.2.4 Selection criteria for the optimal extraction system 
The selection of the best extraction solvent composition was based on visual inspection of the 
supernatants and the strength of the analytical signals of the ten extractions systems described 
in Figure 2.1. The best extraction systems were those exhibiting clearest and brightest 
supernatants and the highest extracted ion chromatogram (EIC) peak areas in ion captured per 
second.  
All of the calculation were carried out in Excel (Microsoft Office Excel 2010).  
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2.3 Results and discussion 
The physical appearance of the ten supernatants obtained after performing the ten extractions 
suggested in Figure 2.1 are  described in Table 2.2.  
 
Table 2.2 Physical appearance of the supernatants after treating the salmon liver with the 
solvents composition indicated in Figure 2.1 
 
Tube* Color of the solution Physical appearance 
A Transparent Clear supernatant  
B Red Thick precipitated layer and no supernatant produced 
C Dark brown Not clear supernatant, Burned-like extract  
D Yellow Clear liquid oily supernatant 
E Red Not clear supernatant, visible precipitation  
F Light brown Not clear supernatant, milky solution. 
G Brown Clear supernatant, visible precipitated layer  
H Red Not clear supernatant, visible precipitation  
I Orange Not clear supernatant, visible precipitation  
J Transparent visible precipitation 
* Tube letter corresponds to the letters indicated in Figure 2.1 
  
 
As noticed from the Table 2.2 all samples B, C, E, F, and H, were not measured instrumentally 
due to the persistency of turbidity after centrifugation, this might be due to the use of pure 
formic acid (99%) which burned the fish tissue. Only the clear and bright supernatants without 
any visible particles (Systems A, D and G) were injected.  
The total ion chromatograms (TIC) for the systems A, D and G are shown in Figure 2.2. 
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Figure 2.2 TIC corresponding to the Blank and one sample of each extraction system A, D, 
and G 
Table 2.3 shows peak areas of extracted ion chromatogram EIC that correspond to injected 
samples, extraction system G, characterized by the use of equal fraction of three solvents in the 
solvent mixture, exhibited the highest relative standards deviation RSD for both LTB4 and 
PGE2. Acetonitrile did not exhibit any instrumental signal for neither PGE2 nor LTB4 when 
used as a blank 
Figure 2.3 shows that the extraction systems A and D produced different TIC. However, Table 
2.3 and Figure 2.3, describing the EIC for A and D, revealed that both systems generated 
approximately similar signals and accepted RSD (<15%).  
The comparison of the PGE2 signal for the extraction system A and D showed a consistent 
slightly higher intensity for the latter system (Figure 2.4). Furthermore, the extraction system 
D was selected as the optimal system for extracting eicosanoids from salmon liver. These results 
are in agreement with those reported elsewhere [1]. System G was discarded due to the high 
relative standard deviations (Table 2.3).  
 
 
 
 
A 
D 
G 
Blank 
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Table 2.3 EIC peak area corresponding to the three extraction system for PGE2 and LTB4.  
Extraction 
systems 
PGE2 LTB4 
Mean RSD % Mean RSD % 
A 132922 8.2 93650 1.7 
D 139880 13.4 86984 13 
G 164612 51.6 117194 84994 
 
 
 
Figure 2.4 EIC peak area averages for both PGE2 and LTB4 corresponding to the three 
extraction systems   
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           Figure 2.4 Monitored extracted ion chromatogram signals for PGE2 and LTB4.  
The retention times for PGE2 and LTB4 were 9.3 min and 11 min respectively, and the 
corresponding mass spectra of both target analytes extracted using the system D is shown in 
Figure 2.5. 
 
      Figure 2.5 fragmentation patterns for PGE2
 and LTB4 using the extraction system D.
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2.4 Conclusions 
Based on the clarity and brightness of the supernatant and signal intensities, the extraction 
system D, consisting of equal amounts of acetonitrile and chloroform (500 µL of each) was 
selected as the optimal solvent composition for extracting PGE2 and LTB4 from salmon liver 
upon the 10 extraction systems investigated. The addition of formic acid dissolved the liver 
tissue and generated turbidity, thus formic has been ruled out. 
The implementation of a simplex lattice design has demonstrated to be a reliable strategy not 
only for selecting the optimal combination of solvents but also for guiding the analyst in the 
rational selection of potential experimental conditions.   
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3. Optimization of internal standard addition 
3.1 Selection of the optimal concentrations of internal standards. 
3.1.1 Response Factor  
In order to assist quantification in LC/MS systems, it is common to use an internal standard 
with a similar chemical structure and properties to that of the analyte of interest. This involves 
preparation of solution of known concentration of analyte [A] spiked with known concentration 
of internal standard [IS], then determination of their signal ratio (SA/SIS) and their response 
factor (RF) computed as: 
 
Therefore, once RF is determined at a given known concentration of spiked IS, the unknown 
concentration of the analyte can be calculated from their response signals, assuming that the 
two factors ([A] and [IS]) exhibit a linear relationship towards the detector over the studied 
range of concentrations. Traditionally, details on the detector linearity are commonly described 
for the analyte alone or in combination with a fixed amount of internal standard, and no 
description is given on how to estimate the best level of internal standard [83]. 
The RF of the internal standard can remain constant or it may vary dramatically over the 
analytical range, The reason could be related to the degree of ionization of the internal standard 
in the electrospray ion source and the interaction between analyte and internal standard [85]. 
Thus the RF and also the accuracy of the determination require optimization of both 
concentration ranges (analytes and internal standards) in order to assure constant RF values 
throughout the analytical ranges. Some researchers have been pointed out that more 
comprehensive studies on how simultaneous changes of the analyte and the internal standard 
affect the response factor RF and therefore, the quantification process, need to be performed. 
[85] 
3.1.2 Experimental design in quantification experiments. 
Several techniques are commonly used in the estimation of an optimal level of internal standard 
and further calculation of RF. For instance, it has been suggested that the analysis of one or two 
levels of internal standard and three levels of analyte is appropriate in order to estimate a reliable 
amount of the former and to build an appropriate curve of the latter [85, 86]. Another approach 
(3.1) 
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is to target the internal standard to the lower 1/3 of the working standard curve in order to have 
a level above the limit of quantification but not so high as to overshadow the analytical signal 
[87]. 
These approaches do not consider the dependence of the response of the internal standard on 
the concentration of the analyte. Consequently, the determination of the dependence of these 
factors is essential. Different models and experimental designs can be used in order to study the 
behavior of RF when [A] and [IS] are varied. The main characteristics and properties of various 
experimental designs are shown in Table 3.1. 
The models described by the different experimental arrangements are: 
RF = b0 + bA[A] + bIS[IS]            (3.2) 
RF = b0 + bA[A] + bIS[IS] + bA×IS[A] ×[IS]                (3.3) 
RF = b0 +bA[A] + bIS[IS] +bA
2[A]2 +b2IS[IS]
2+ bA×IS[A]×[IS]                                        (3.4) 
 
Where b0 represents the intercept, bA and bIS the linear term coefficients, bA×IS the first order 
interaction effect coefficient and b2A and b
2
IS are second order curvature effect coefficients. 
The number of degrees of freedom is an important parameter that should be considered when 
judging the lack of fit of a model the degrees of freedom in Table 3.1 are defined as the 
minimum number of experiments minus the number of parameter in the model. The term 
efficiency (E) in Table 3.1 which measures the relationship between the number of estimated 
coefficients and the amount of effort put into the execution of the experiments is defined by the 
expression: 
 
In quantification experiments aiming at studying the behavior of RF and the optimal amount of 
internal standard, values of E lying between 0.40 and 0.60 can be considered acceptable. 
 
 
 
 
 
 
 
(3.5) 
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Table 3.1 Main characteristics of the various experimental designs discussed in this section* 
 
Design 
 
 
 
 
 
 
Factorial 
 
 
 
 
 
 
 
 
Sequential 
 
 
 
 
 
 
 
 
 
 
 
 
Simultaneous 
Type Experimental 
arrangement 
Minimum number 
of 
experiments for 
N=2 variables 
Number of 
[A]levels 
Number 
of 
[IS]level
s 
Model Degrees 
of 
freedom 
Efficiency 
2 levels 
 
 
2N = 4 exp 
2 2 Eq. (3.2) 
Eq. (3.3) 
1 
0 
0,75 
1 
3 levels 
 
 
3N = 9 exp 
3 3 Eq. (3.2) 
Eq. (3.3) 
Eq. (3.4) 
6 
5 
3 
0.33 
0.44 
0.67 
 
Simplex 
 
 
N+1=3 exp 
3 3 Eq. (3.2) 
 
0 1 
Star 
 
 
2N+1=5 exp 
3 3 Eq. (3.2) 
Eq. (3.4) 
 
2 
0 
0.6 
1 
Central 
composite 
 
 
2N+2N+1=9 exp 
5 5 Eq. (3.2) 
Eq. (3.3) 
Eq. (3.4) 
6 
5 
3 
0.33 
0.44 
0.67 
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Uniform shell 
 
 
2N+N+1=7 exp 
3 5 Eq. (3.2) 
Eq. (3.3) 
Eq. (3.4) 
4 
3 
1 
0.43 
0.57 
0.86 
* Table adopted from  Analyst, 1997, 122, 621–630. 
 
Factorial design seems a simple and adequate approach to model the effect of the two variables 
with a minimum number of experiments. However, the disadvantages of this design are the few 
levels of analyte and internal standard studied and the lack of degree of freedom to estimate the 
lack of fit errors. Higher level factorial design is not advisable due to the low number of 
concentration levels studied compared to the high number of experiments performed [85]. 
Simplex designs are limited by the lack of degree of freedom when a minimum number of 
experiments is considered. Star design offers a reasonable number of experiments, 
concentration levels and degrees of freedom although they cannot estimate first order 
interaction effects A central composite design adding four more experiments and providing 
more concentration levels can overcome this.  
Uniform shell design, specifically a Doehlert design [88], allows the study of the same number 
of models as the central composite design with a minimum number of experiments, allocated 
in a regular hexagon with a point in the center (Figure 3.1). The design generates information 
equally spaced in all directions since the experimental points are equally distributed on the 
surface of spherical shell and each point in the design has equal distance to the center as well 
to its neighbor experimental points (Figure 3.2a). In addition, it is possible to extend the 
experimental matrix and study other experimental arrangements by using previous experiments 
(Figure 3.2b). 
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Figure 3.1 The two-factor (x1, x2) Doehlert design. The design has the five experimental levels 
along X1 dimension with coded value -1.00, -0.50, 0.00, 0.50 and 1.00 respectively. Similarly 
the three experimental levels along X2 dimension have coded value -0.866, 0.000 and 0.866 
respectively. 
 
 
 
Figure 3.2 Doelhert design properties: a. spatial distribution of the experimental points; b. 
extension of the initial matrix by using previous adjacent points. 
 
One characteristic of this type of design is the unequal number of experimental levels at the 
different axes. When studying two factors, one factor is varied over three levels while the other 
is varied over 5 levels, as can be seen from figure 3.2a. This is an important feature, as there 
are often cases where the factors under study are subjected to different ranges and levels and to 
avoid unnecessary experiments [83]. 
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3.1.3 Number of replicates 
 
In quantification experiments, where the preparation error is always larger than the instrumental 
error, the use of replicates is essential in order to decrease the associated errors [89]. 
Uncertainty of an experimental design measures how confidently a model predicts data in an 
experimental region; the greater uncertainty indicates less confidence in the predictions. For a 
given experiment, i, in a design matrix X, the uncertainty can be defined by: 
Un
2   = s2 e    [1+xi(X'X)
-1
x
i
']      (3.6) 
Where se is the squared residual error over the total number of experiments N. The term 
x
i
 (X'X)-1x
i  
depends only on the design and not on the experimental response, so it is possible to 
predict the uncertainty without performing any experiment by changing the levels of the 
variable xi across the domain of the factor space [89]. 
When several replicates are introduced in the design matrix, the uncertainty of prediction of the 
mean of q values (where q is the number of the replicates)  is given by: 
 
Un
2   = s2e   [1/q + xi (X'X)
-1
x
i
']                                                                                                        (3.7) 
The equation (3.7) shows that uncertainty of an experimental design is influenced by the 
number of replicates, so it is important to determine in advance the number of replicates [89]. 
The number of replicate in the design matrix also affects the term x
i
 (X'X)-1x
i
 as it will explained 
in the next section. 
 
3.1.4 Leverage 
The term x
i
 (X'X)-1x
i
 is a measure of the potential influence of an observation on the parameter 
estimated and is usually called Leverage, h [89]. 
The leverage can be calculated to show how confidence changes when the design or model is 
altered.  
The Matrix H= X(X'X)-1X' is called the hat matrix and it has the property that its diagonal 
elements equal the leverage at each experimental point [89]. Tables 3.2 and 3.3 show the design 
matrix and the hat matrix for a central composite design respectively when two factors in 
triplicate (q=3) are considered. 
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The sum of leverage over all experimental points equals the number of coefficients in the model, 
thus the more replicates used the smaller the leverage is, For instance, the model proposed in 
(Eq. 3.2) involves three coefficients, so the hat matrix of the previous design example presented 
in Table 3.3 will demonstrate that no matter how many experiments are carried out, the 
summation over all the diagonal elements of the hat matrix will always be three, therefore 
introducing more replicates in the design matrix will reduce the leverage and thus reduce the 
uncertainty in the proposed model. Also, as shown in Table 3.2, the leverage is less in the region 
where the experimental points are close to the center and the leverage has equal value over all 
the points that has the same distance from the center.  
In the uniform shell design (Figure 3.1), all the experimental points (except the center points) 
have the same uncertainty since it has the same distance from the center point, unlike other 
types of the designs where the uncertainty varies between experimental points. 
 
Table 3.2 Central composite design matrix used as example to calculate the leverage matrix 
where 5 levels of the variables x1 and x2 are considered, and b in the intercept. 
 
Experiment 
number b x1 x2 
1 1 -2 -0 
2 1 -1 -1 
3 1 -1 -1 
4 1 -0 -0 
5 1 -0 -2 
6 1 -0 -2 
7 1 -1 -1 
8 1 -1 -1 
9 1 -2 -0 
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Table 3.3 Computation of the hat matrix X(X'X)-1X'  for the design matrix given in Table 3.2 
 
0,44 0,28 0,28 0,11 0,11 0,11 -0,06 -0,06 -0,22 
0,28 0,28 0,11 0,11 0,28 -0,06 0,11 -0,06 -0,06 
0,28 0,11 0,28 0,11 -0,06 0,28 -0,06 0,11 -0,06 
0,11 0,11 0,11 0,11 0,11 0,11 0,11 0,11 0,11 
0,11 0,28 -0,06 0,11 0,44 -0,22 0,28 -0,06 0,11 
0,11 -0,06 0,28 0,11 -0,22 0,44 -0,06 0,28 0,11 
-0,06 0,11 -0,06 0,11 0,28 -0,06 0,28 0,11 0,28 
-0,06 -0,06 0,11 0,11 -0,06 0,28 0,11 0,28 0,28 
-0,22 -0,06 -0,06 0,11 0,11 0,11 0,28 0,28 0,44 
 
 
Star design points leverage value 
 
 
Central point leverage value 
 
 
Factorial design points leverage value 
 
A comparison between different types of design in terms of the highest and the lowest 
uncertainty is shown in the table 3.4. The comparison shows that the uncertainty decreases 
when the number of replicates in the design matrix increases. Although the central composite 
design has the lowest uncertainty, the high number of experiments favors the uniform shell 
design.   
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Table 3.4 comparison between different types of design in terms of the highest and the lowest 
uncertainty. 
Design 
Type 
Number of 
experiments 
Highest 
uncertainty 
Lowest 
uncertainty 
Comment 
Simplex 3 1,000 1 3 experimental points 
6 0,500 0,5000 3 duplicated experimental points  
15 0,200 0,2000 3 triplicated experimental points  
Star 5 0,7000 0,2000 5 experimental points 
10 0,3500 0,1000 5 duplicated experimental points 
15 0,2330 0,6660 5 triplicated experimental points 
Central 
composite 
9 0,4440 0,1110 9 experimental points 
18 0,2220 0,0556 9 duplicated experimental points  
27 0,1480 0,0370 9 triplicated experimental points  
Uniform 
shell 
7 0,4760 0,1420 7 experimental points 
14 0,2380 0,0710 7 duplicated experimental points 
21 0,1580 0,0476 7 duplicated experimental points 
 15 0,2333 0,0660 7 duplicated experimental points 
with one and two triplicated 
experiments 
 17 0,2150 0,0582 
 
Figures 3.3 and 3.4 show the changes in the uncertainty associated with central composite 
designs and uniform shell design respectively when different number of replicates are used. 
 
 
                                                   Optimization of internal standard addition  
29 
 
 
 
Figure 3.3 Changes in uncertainty in a central composite designs when different number of 
replicates are introduced. 
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Figure 3.4 The changes in the uncertainty associated with uniform shell design when different 
number of replicate used. 
A comparison between Figures 3.3 and 3.4 allows concluding that a Doehlert design is an 
optimal strategy for optimizing the amount of internal standard to be used in connection with 
the analysis of eicosanoids in salmon liver. In addition, a close inspection of Figure 3.4, shows 
that the best replication regimes, with the lowest uncertainty, are those represented by the green 
and purple traces, corresponding to a total of 21 and 17 experiments respectively.  
 
3.1.5 Selection of the design  
The uniform shell design of 17 experiments described in Figure 3.4 (purple trace) was the 
selected choice in terms of the relative low number of experiments. The matrix with 21 
experiments was not considered due to the fact that the uncertainty (green trace in Figure 3.4) 
did not much decrease when introducing 4 more experiments (n=17+4). 
Since a blank sample (wild salmon liver with an undetectable level of eicosaoinds) was not 
available, 3 more experimental points that involve the addition of 3 different levels of internal 
standard to estimate the endogenous level of eicosanoid in the liver sample were added. The 
extra points in questions are represented in Figure 3.5 with a red circle. The final design matrix 
is described in Table 3.5. 
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Figure 3.5: Selected experimental points to estimate the response factor. 
Black circles corresponds to uniform shell design experimental points, while red circles 
indicate samples only spiked with internal standard, also, the number in the circle indicates 
the number of replicates. 
Experimental points marked with stars correspond to standard addition method experimental 
points.  
 
Levels of PGE2 in different fish tissues (e.g. brain, kidney and heart) have been reported to be 
up to 50 pg/mg [90, 91]. Based on this concentration, the investigated analytical range for both 
PGE2 and LTB4 was set to be 1-50 ng/g. 
The studied range for the PGE2-d4 and LTB4-d4 was sat to be 15-50 ng/g assuming that the 
level of internal standard addition should be above the lower 1/3 of the working analyte range. 
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Table 3.5 the selected design matrix to estimate the response factor and the endogenous 
eicosanoids concentration  
 
Experiment 
No. 
Coded level Natural level (ng/g) 
 x1 x2 x1 x2 
   PGE2 LTB4 PGE2-d4 LTB4-d4 
1 -0.0 -00.00 25.00 25.00 32.5 32.5 
2 -0.5 -0.866 37.25 37.25 17.3 17.3 
3 -0.5 -0.866 13.20 13.20 47.7 47.7 
4 -0.5 -0.866 13.20 13.20 17.3 17.3 
5 -0.5 -0.866 37.25 37.25 47.7 47.7 
6 -1.0 -00.00 01.00 01.00 32.5 32.5 
7 -1.0 -00.00 50.0 50.00 32.5 32.5 
8 -NP -0.866 00.00 00.00 17.3 17.3 
9  NP -00.00 00.00 00.00 32.5 32.5 
10  NP -0.866 00.00 00.00 47.7 47.7 
   NP: not present 
 
3.1.6 RF Modeling 
RF behavior was studied and modeled by using Doehlert uniform shell design where the 
concentrations of the PGE2 and LTB4 with their respective deuterated internal standards were 
varied simultaneously (Table 3.5). 
The RF was calculated by Eq. 3.1 at each of Doehlert design experimental points based on the 
obtained signal area of analyte and internal standard. Then the RF was explained or modeled 
based on the models in Eq. 3.4. The adequacy of the developed models was evaluated by the 
variance ratio test or Fisher ratio test (F-Test). 
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The F-test is a statistical parametric test commonly used to compare the lack-of-fit to pure error 
variances of a predetermined mathematical model. This statistical test is applied by calculating 
the variances of the lack-of-fit and pure errors by dividing their summation with respective 
degrees of freedom. The ratio of variance of the lack-of-fit error to that of pure error is known 
as experimental F-value (FCal) and used to conclude if the model fits the data by comparing 
with the theoretical (tabulated) F-value (Ftab). The process of an F-test can be seen in Table 3.6. 
Table 3.6 The calculation of F test parameter to check the fitness of the model. 
N, P, K are the number of total experiments, number of regression coefficients and number of 
experimental points respectively. 
 
Parameter Equation 
Variance of residual error (VRE) 
 
Variance of pure error (VPE) 
 
Variance of lack of fit (VLOF) 
 
Calculated F (cal) 
 
 
If FCal is less than Ftab, it means that the model explains the experimental data confidently. In 
some cases, it is possible to remove the non-significant regression coefficients in the Eq. 3.4 to 
increase the degrees of freedom and obtain a simpler model (reduced model). In this thesis, all 
the theoretical F-values were calculated at the 95 % confidence level of the F-distribution. Basic 
calculations, statistics and F-test were carried out in Excel 2010. 
3.1.7 Estimation of endogeanous concentration by standard addition method. 
The endogenous concentrations of PGE2 and LTB4 were estimated using the standard addition 
method, In this method, different amounts of standard are directly added to some aliquot of the 
sample and then the instrumental signal corresponding to these samples are determined. The 
results are plotted as shown in Figure 3.6, where the signal is plotted on the y-axis while the x-
axis is graduated in terms of the concentration of analyte added. A regression line is estimated 
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and extrapolated to the point on the x-axis at which y = 0. This negative intercept on the x-axis 
corresponds to the amount of the analyte in the test sample [92]. 
In order to reduce errors related to the instrumental signal determination and systematic matrix 
effect, a constant amount of deuterated standard was added to each sample, and the signal of 
the analyte to the signal of the deuterated standard ratio S
A
/S
IS was plotted on the y-axis. This 
methodology is particularly recommended in procedures for pesticide or drug residue analysis 
and other contaminants in food and biological matrices [93]. 
 
 
Figure 3.6 The estimation of the analyte concentration by the standard addition calibration. 
The curve on the left is plotted by preparing six separate calibration standards, and the curve 
on the right is plotted by performing three measurements on the original sample and three 
replicate measurements on a spiked sample containing a substantial amount of added analyte. 
It is worth to be mentioned that the generated regression model must be linear over the studied 
range of added concentration, thus, the linearity was verified using the lack of fit method 
mentioned previously. 
The formula for the standard deviation, SxE of the extrapolated x-value (xE) is given by the 
equation: 
 
 
(3.8) 
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Where b is the slope, n is the number of observation and sy/x is the residual standard deviation. 
Thus, increasing the number of experiments reduce the extrapolated result imprecision, also 
winding the range of the analyte added concentration will increase the value ∑ (𝑥𝑖 −  𝑥𝑖 )
2 and 
reduce SxE. 
It is recommended to use six separate calibration standards (Figure 3.6, left), or perform three 
measurements on the original sample and three replicate measurements on a spiked sample 
containing a substantial amount of added analyte (Figure 3.6, right) [92]. However due to the 
lack of degrees of freedom, the latter approach was excluded.  Moreover, due to the limitation 
of the salmon liver sample, it was decided to perform a total measurements of nine samples 
representing four experimental points (Figure 3.5).  
3.2 Experimental 
3.2.1 Reagents 
Prostaglandin E2 (PGE2, 99%), deuterated prostaglandin E2 (PGE2-d4, 99%), leukotriene B4 
(LTB4, 97%), deuterated leukotriene B4 (LTB4-d4, 99%) were purchased from Cayman 
Chemical (Ann Arbor, MI, USA). Acetonitrile (liquid chromatographic grade, 99.8) was 
obtained from Sigma-Aldrich (St. Louis,MO, USA) and Chloroform (liquid chromatographic 
grade, 99.8%) was bought from Merck (Germany). Liquid nitrogen and dry ice were provided 
by Tess (Norway). 
3.2.2 Samples preparation. 
The initial concentrations of PGE2, LTB4, PGE2-d4, LTB4-d4 was 50 ng/ml, two stock 
solutions, designated as A and B, were prepared. Solution A containing 50 ng/ml of both PGE2 
and LTB4 and solution B containing 50 ng/ml of both PGE2-d4 and LTB4-d4. 
A wild salmon liver sample stored at -80°C was treated according to the above described 
extraction procedure (sub-section 2.2.2).  
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Table 3.7 Concentrations of PGE2, LTB4, PGE2-d4 and LTB4-d4 in frozen liver sample at each 
experimental point of a two-variable Doehlert design 
 
Experiment 
No. 
Coded level Natural level (ng/g) Amount 
added from 
solution A 
µL 
Amount 
added from 
solution B 
µL 
 k1 k2 k1 k2   
   PGE2 LTB4 PGE2-d4 LTB4-d4   
1 -0 -0 25.00 25.00 32.5 32.5 150.0 195.0 
2 -0.5 -0.866 37.25 37.25 17.3 17.3 223.5 103.8 
3 -0.5 -0.866 13.20 13.20 47.7 47.7 79.20 286.2 
4 -0.5 -0.866 13.20 13.20 17.3 17.3 79.20 103.8 
5 -0.5 -0.866 37.25 37.25 47.7 47.7 223.5 286.2 
6 -1.0 -0 01.00 01.00 32.5 32.5 6.000 195.0 
7 -1.0 -0 50.0 50.00 32.5 32.5 300.0 195.0 
8* -NP -0.866 00.00 00.00 17.3 17.3 00.00 130.8 
9* -NP -0 00.00 00.00 32.5 32.5 00.00 195.0 
10*  NP 0.866 00.00 00.00 47.7 47.7 00.00 286.2 
*NP: Not present 
Sample replication regime was corresponding to thr Figure 3.5 
 
3.2.3 HPLC-MS/MS analysis  
 
The LC/MS apparatus and the various instrumental and measurement conditions have been 
described above (section 2.2.3) however, the total analysis time was set to 20 min. 
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3.3 Results and discussion 
 
The RF behavior for the COX metabolite (PGE2 and PGE2-d4) and the LOX metabolites (LTB4 
and LTB4-d4) were modeled using a full-second order polynomial function with six coefficients 
(Eq. 3.4). Reduced models were also considered by ruling out less contributing coefficients. 
This was done when the adequacy and prediction capacity of the reduced model was not 
significantly affected in comparison with the six coefficients model. The fitness of the 
developed models was validated by comparing the ratio of experimental lack-of-fit to pure error 
variance at the determined degrees of freedom Fcal with Fcrit as explained previously.  
The variation of the analytes concentration between samples due to the differences in samples 
initial weight was considered (Appendix 1). 
 
3.3.1 Modeling of the RF as a function of PGE2 and PGE2-d4  
The signal of the blank sample was initially subtracted from the experimental signals 
corresponding to the spiked samples dictated by the Doehlert design to eliminate the 
contribution of the endogenous level. 
The experimental RF values at the various levels of concentrations of PGE2 and PGE2-d4 were 
modeled successfully by using a six parameters regression models described by Eq. 3.4. This 
six parameters model was reduced to a four parameters model and expressed by: 
RF = - 4.61+ 0.0306 ×[PGE2] +0.014×[PGE2-d4] - 0.009×[PGE2]×[PGE2-d4]                    (3.9) 
The statistical acceptability of Eq. 3.9 was checked by means of a F-test as shown is Table 3.8. 
The RF variation as a function of PGE2 in the range of 0 - 50 ng/g and PGE2-d4 in the range of 
15-50 ng/g and according to Eq. 3.9 is presented in Figure 3.7. 
 
The contour plot (figure 3.7) revealed that the RF remains constant in the whole range of PGE2 
when the internal standard is varied between (31.5 -32.5) ng/g. 
 Based on the RF behavior (Figure 3.7), a concentration of 31 ng/g of PGE2-d4 was selected as 
the optimal concentration of PGE2-d4 internal standard to analyze quantitatively PGE2 in 
salmon liver. 
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Figure 3.7 Contour plot of the response factor (RF) expressed as a function of PGE2-d4 vs. 
PGE2 
 
Table 3.8 Statistical validation results of the RF models for selecting optimal levels of internal 
standards associated with the analysis of LTB4 and PGE2 Salmon Liver. 
 PGE2 LTB4 
Residual Variance 12.46 0.23 
Pure Error Variance 16.97 0.14 
Lack Of Fit Variance 3.39 0.35 
F calculated 0.199 2.49 
F tabulated 3.700 3.700 
 
 
3.2 Modeling of the RF as a function of LTB4 and LTB4-d4 
Similarly to the COX metabolite, the experimental RF values at the various levels of 
concentrations of LTB4 and LTB4-d4 were modeled successfully, after subtracting the blank 
signals, by using a six parameters model of the form: 
RF = - 4.61+ 0.306× [LTB4] - 0.140× [LTB4-d4] - 0.009×[LTB4] [LTB4-d4]            (3.10) 
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The statistical acceptability of Eq. 3.9 was checked by means of a F-test as shown is Table 3.8. 
The model could not be reduced furtherly.  
The RF contour plot generated by Eq. 3.10 as a function of LTB4 and LTB4-d4 in the range of 
0 - 50 ng/g and 15-50 ng/g respectively (Figure 3.8) displays three major regions, in which RF 
varied along LTB4 axis, however, with the high concentration of LTB4-d4 (between 45-50 ng/g) 
the RF tends to be constant over the whole LTB4 studied concentration range. 
Based on the RF behavior (Figure 3.8) a concentration of 47.5 ng/g of LTB4-d4 was selected as 
the optimal concentration level of internal standard to analyze quantitatively LTB4 in salmon 
liver. 
 
Figure 3.8 Contour plot of the response factor expressed as a function of LTB4-d4 vs. LTB4. 
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3.3.3 Standard Addition Method to estimate the endogenous levels of eicosanoids  
The quantification of endogenous levels of PGE2 and LTB4 were performed by the method of 
standard addition as follows. From the results of the previous Doelhert design (Table 3.5), 
calibration curves for PGE2 and LTB4 were generated and the concentration of the eicosanoids 
in the blank samples determined.  
Each calibration curve was constructed from sets of four experimental points corresponding to 
three different levels of analyte (1, 25 and 50 ng/g) and one from the unspiked working samples. 
Each selected point contained constant amounts of PGE2-d4 and LTB4-d4 (32.5 ng/g) which 
were added to each sample.  
Two samples were prepared for each point except the point that correspond to 25 ng/g of added 
analyte (the central point of the Doelhert design) of which three samples were prepared. 
The signal ratios PGE2/PGE2-d4 and LTB4/LTB4-d4 were plotted versus the concentrations of 
PGE2 and LTB4 respectively. Figure 3.9 shows the standards addition method regression curve 
for both PGE2 and LTB4. 
The analyte endogenous concentration in the unspiked working samples was determined by 
extrapolating the calibration curve to the negative part of the concentration axis. Then, the 
absolute value of the x-intercept was calculated to estimate the amount of PGE2 and LTB4 in 
the unspiked blank salmon liver. The results in Table 3.9 showed that the endogenous levels 
were found 101.46 ±48.48 ng/g and 86.67±41.28 ng/g with the confidence level of 95% for 
both PGE2 and LTB4 respectively.  
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Figure 3.9 standards addition method regression curve for both PGE2 and LTB4 Where [A] is 
the analyte concentration and SA/SIS in the signal of the analyte to the signal of the internal 
standard ration. 
Table 3.9 Quantification of PGE2 and LTB4 in working sample using the standard addition 
method 
 PGE2 LTB4 
Standard addition Calibration line slop 0.017 -0.108 
Standard addition Calibration line intercept 1.73 9.27 
Endogenous concentration ng/g  101.46 86.67 
RSD% 16.28 16.44 
 
Figure 3.9 shows that generated the linear regression curve that correspond to LTB4 had a 
negative slop, this could be due to the major variation of the response factor, as shown in Figure 
3.8., when using the concentration of 32.5 ng/g of  internal standard. 
Also, the LTB4 production might differ within the same liver, depending on which type of liver 
cells the samples contain the most. For instance LTB4 are produced in both hepatocyte and 
kupffer cells but not in the endothelial cells [5], these points might have affected the sensitivity 
of the test and caused a negative slop, however, suggestion regarding the method improvement 
and sample homogenization are given in section 4.8. 
 
                                                   Optimization of internal standard addition  
42 
 
3.3.4 Remodeling of the RF as a function of PGE2 and PGE2-d4 by considering the contribution 
of the endogenous levels (101 ng/g) in the blank salmon liver 
 
By considering the endogenous level of 87 ng/g, the analytical range of 87-137 ng/g was 
estimated and the behaviors of the RF was studied as explained above (section 3.3.1). The 
results indicated that the suggested model was found as follows: 
 
RF = -7.26 +0.074×[PGE2] +0.38×[PGE2-d4] -0.003×[PGE2]×[PGE2-d4]                          (3.11) 
The suggested model was validated by the mean of F-test as mentioned in table 3.10. 
The RF behavior over the studied range is represented in the Figure 3.10, The RF tends to be 
constant when the level of internal standard varied between (20-31) ng/g 
 
 
Figure 3.10 Contour plot of the response factor (RF) expressed as a function of PGE2-d4 vs. 
PGE2 After considering the endogenous level of LTB4. 
 
 
 
                                                   Optimization of internal standard addition  
43 
 
3.3.5 Remodeling of the RF as a function of LTB4 and LTB4-d4 by considering the contribution 
of the endogenous levels (87 ng/g) in the blank salmon liver 
 
By considering the endogenous level of 87 ng/g, the analytical range of 87-137 ng/g was 
estimated and the behaviors of the RF was studied as explained above (section 3.3.2). The 
results indicated that the suggested model was found as follows: 
 
RF = - 6.85 + 0.1× [LTB4]- 0.04× [LTB4-d4]- 0.002×[LTB4] [LTB4-d4]+ 0.0022 [LTB4-d4]
2
                                                                                                                          
(3.12) 
The statistical acceptability was checked by F-test. Table 3.10. 
The RF was studied over the whole range using the equation 3.12, and plotted in Figure 3.11, 
the RF tends to be constant when the concertation of internal standard was set to be 50 ng/g. 
 
Figure 3.11 Contour plot of the response factor expressed as a function of LTB4-d4 vs. LTB4 
After considering the endogenous level of LTB4 
In order to assess the variability of the RF over the studied range on analyte concentration, 
another approach was used: 
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Using both equations 3.11 and 3.12, the RF was calculated along the whole studied range of 
87- 101-151 ng/g and 137 ng/g for both PGE2  and LTB4 respectively and the range of 15 – 50 
ng/g regarding both PGE2-d4 and LTB4-d4. And the variability of RF PGE2 and RF LTB4, 
expressed as relative standard deviation (RSD) was studied (Fig.3.12). 
The RSD increased in the whole range of PGE2 as the concentration of PGE2-d4 increased in 
the range of 15–50 ng/g. While the RSD decreased in the whole range of LTB4 as the 
concentration of LTB4-d4 increased in the range of 15–50 ng/g. 
On average, it was estimated that the optimal concentrations of PGE2-d4 and LTB4-d4 yielding 
constant RF PGE2 and RF LTB4, in the whole range of PGE2 and LTB4 and with the minimum 
dispersion, lies between 25-30 ng/g and 45-50 ng/g respectively. 
The optimal selected concentration was 25 ng/g and 50 ng/g for both of PGE2-d4 and LTB4-d4 
respectively. 
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Figure 3.12 Average PGE2 and LTB4 response factors (RF PGE2 and RF LTB4) and associated 
relative standard deviations (RSD%) at different concentration ranges of PGE2-d4 and LTB4-
d4. The green bars represent optimal concentrations of internal standards (in ng/ml) yielding 
constant RF and minimum RSD in the whole range of analytical concentrations. 
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Table 4.1 PGE2 and LTB4 calibration curves regression coefficients and statistical validation 
results for the obtained model. 
 PGE2 LTB4 
Correlation Coefficient  0.40   0.48 
Variance of residual error (VRE) 0.71   0.18 
Variance of pure error (VPE) 0.48 60.20 
Variance of lack of fit (VLOF) 0.62    0.85 
Calculated F (Fcal) 1.30    0.96 
Tabulated F (F tab) 5.78    5.78 
 
3.4 Conclusions 
The two-factor Doehlert uniform shell design demonstrated to be an efficient strategy to 
estimate rationally and comprehensively the optimal levels of internal standards, specifically 
PGE2-d4 and LTB4-d4, in addition to the analytical range for PGE2 and LTB4 where is expected 
a linear behavior.  
The optimal concentration was found 25 ng/g and 50 ng/g for both of PGE2-d4 and LTB4-d4 
respectively. 
Standard addition method was performed to estimate the endogenous level of eicosanoids in 
the working sample, the endogenous level was found 101.46 ±48.48 ng/g and 86.67±41.28 ng/g 
with the confidence level of 95% for both PGE2 and LTB4 respectively.  
. 
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4. Method Validation 
Method validation is the confirmation of the method precision and reliability by defining the 
characteristic of the method to guarantee that the procedure, when correctly applied, produces 
results that are fit for purpose [1, 82]. 
After the selection of the optimal internal standard concentrations, the developed LE-HPLC-
MS/MS method was submitted to analytical validation. The considered validation parameters 
were: selectivity, limit of detection, limit of quantification, linearity, analytical range, precision 
recovery and stability. 
4.1 Selectivity 
Selectivity of a method is defined by the ability of the method to determine a particular analyte 
in a complex mixture without interference from other components in the mixture [95]. 
In chromatographic techniques compounds are separated and eluted in different retention times 
which can guarantee the selectivity, the selectivity is assessed by the terms Resolution (Rs) 
which is defined by the equation: 
Rs  =
Δ𝑡
1
2 
(𝑊𝐴−𝑊𝐵)
                       (4.1) 
While Δ𝑡 is the separation time difference between two peaks and W is chromatographic peak 
width at base [1, 95]. 
When the chromatographic method is coupled with mass spectroscopy, the mass spectra 
guarantee more selectivity [96]. 
In this thesis the selectivity was assessed by evaluating the extracted ion chromatogram EIC of 
PGE2, LTB4, LTB4 –d4 and PGE2 - d4. As shown in Figure 4.1, the method was highly 
selective, this selectivity allows the use of isotopically labelled analytes as internal standards, 
and distinguish between the obtained signals.  
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    Figure 4.1 EIC of PGE2, LTB4, LTB4 –d4 and PGE2 -d4 spiked in a wild salmon    liver 
sample. 
 
4.2 Linearity 
  
Linearity is the ability of an analytical method to provide an analytical response proportional 
to the concentration or the amount of analyte within a specified range of analyte concentration 
[83]. 
Linearity is expressed by the linear regression equation: 
𝑦 = 𝑎 (𝑥) + 𝑏                                                         (4.2) 
Where y, in the present study, is the analyte/internal standard signal ratio, x is the analyte 
concentration and a and b are the slope an intercept of the calibration function respectively.  
In common practice the linearity of a calibration curve is assessed by calculating the correlation 
coefficient (r) [95]. 
 
r =  
𝑛 ∑ 𝑥𝑖𝑦𝑖−∑ 𝑥𝑖 ∑ 𝑦𝑖
√[𝑛 ∑ 𝑥𝑖
2−(∑ 𝑥𝑖)2][𝑛 ∑ 𝑦𝑖
2−(∑ 𝑦𝑖)
2]
              (4.3) 
 
A correlation coefficient close to unity (r = 1) is traditionally considered sufficient evidence to 
conclude that the experiment has a perfect linear calibration. However, the correlation 
coefficient close to one does not necessarily imply the linearity of a regression model. 
Moreover, the linearity must be checked using the F-test previously described in the section 
3.1.6.  
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The developed method was assessed by using Eq. 4.2 in the range of 1-50 ng/g of PGE2 and 
LTB4 and the linearity of the model for both analytes assessed by the F-test as indicated in 
Table 4.1. 
 
Table 4.1 PGE2 and LTB4 calibration curves regression coefficients and statistical validation 
results for the obtained model. 
 PGE2 LTB4 
Slop a 0.017 -0.107 
Intercept b 1.720 9.274 
Correlation Coefficient  0.402 0.484 
Variance of residual error (VRE) 0.710 0.180 
Variance of pure error (VPE) 0.480 0.600 
Variance of lack of fit (VLOF) 0.620 0.850 
Calculated F (Fcal) 1.300 0.960 
Tabulated F (F tab) 5.780 5.780 
 
 
4.3 Precision 
 
Precision is defined as the closeness of agreement between a quantity values obtained by series 
of replicate measurements of the same quantity under the prescribed conditions [95]. 
Repeatability, intermediate precision and reproducibility are three terms associated with 
precision [1]. 
Repeatability is the precision of results obtained in the same measurement conditions (global 
factors) such as analyst, preparation, laboratory, instrument, etc. over a short period of time 
while the intermediate precision is the precision of results obtained in a given laboratory over 
an extended period of time [1]. 
Reproducibility is the precision of results obtained by changing one or more global factors over 
a short or an extended period of time. 
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It is expressed by the standard deviation (SD), variance (SD2), relative standard variation (RSD) 
or coefficient of variation (CV) of replicate measurements and given by the following 
equations: 
SD = √
∑  (𝑥𝑖−?̅?)
2𝑛
𝑖=0
𝑛−1
2
                                                  (4.4) 
RSD = 
𝑆𝐷
?̅?
                                                                (4.5) 
CV =  
𝑆𝐷
?̅?
× 100                                                        (4.6)    
Where ?̅? is the mean value, n is number of measurements and n-1 is the degrees of freedom 
[83]. 
4.4 Accuracy  
 
Accuracy is the degree of agreement between the experimental value, obtained by replicate 
measurements, and the accepted reference value [83]. 
Among different strategies to estimate the accuracy of a method, the terms recovery was used 
as a numerical value to assess accuracy in this thesis, this was mainly because a blank sample 
of salmon liver was not available as nor was certified reference material. 
The recovery, expressed in percentage units (%), of an analytical method for a given analyte in 
a certain biological sample is calculated by using the general formula: 
Rec =  
𝐶𝑚
𝐶+
 × 100                              (4.7) 
Where Rec is recovery, Cm is the analyte concentration measured by the analytical method in 
the biological sample, and C+ is the known nominal concentration of the analyte added to the 
sample [97]. 
However, when the analyte naturally exists in the biological sample at a basal concentration 
level (endogenous level) C0,Ln this concentration must be considered and subtracted from the 
measured concentration Cm, when calculating the methods recovery for the analyte for each 
added concentration [97] 
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Thus, the recovery of endogenous substances in their biological matrices is calculated using the 
formulas: 
Rec = 
𝐶𝑚−C0,𝐿𝑛  
𝐶+
 × 100                      (4.8) 
In this thesis, the precision and accuracy was estimated from Doelhert design experiments by 
calculating the coefficient of variation and recovery obtained from duplicate spiked liver 
samples with low and high levels of PGE2 and LTB4 (1, and 50 ng/g respectively) and triplicate 
samples spiked with medium concentration level (25 ng/g) measurements. All samples were 
spiked with constant level of PGE2-d4 and LTB4-d4 (32.5 ng/g) and the results are shown in 
Table 4.2. 
4.5 Limit of detection (LOD) and limit of quantification (LOQ) 
The LOD is the lowest concentration or amount of an analyte in a sample that can be detected, 
but not necessarily quantified whereas the LOQ is the lowest concentration of an analyte in a 
sample that can be determined with acceptable level of confidence [95]. 
LOQ and LOD are usually  calculated from at least six blank analysis results, the LOD is 
defined as the analyte concentration corresponding to the sample blank value plus three 
standard deviation and LOQ is the analyte concentration corresponding to the sample blank 
value plus 10 standard deviations [83]. 
LOD = ?̅? +  3 𝑆𝐷𝑏𝑙𝑎𝑛𝑘        (4.9) 
LOQ = ?̅? +  10 𝑆𝐷𝑏𝑙𝑎𝑛𝑘      (4.10) 
LOQ = 3.3 LOD                   (4.11) 
Where ?̅? is the average of concentration estimation of the blank (usually zero) and SD blank. 
Therefore, both LOD and LOQ have experimentally measured values and require the 
availability of a blank sample. However, in the case of this study a blank sample was not 
available.  
It was suggested that the actual LOQ of a method for endogenous substances is the lowest added 
analyte concentration, CLOQ, to the biological sample that can be measured with acceptable 
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accuracy (Rec %) and precision (CV) and that can be discriminated statistically significantly 
from the basal concentration C0,Ln of the analyte in relevant biological sample [96]. 
Furthermore, an additional performance parameter has been suggested, The relative limit of 
quantification, rLOQ, as the ratio of the lowest added analyte 
concentration Clow+ to the basal natural concentration C0,Ln, and calculated from the equation: 
rLOQ =  
𝐶LOQ
𝐶0,Ln
 
 × 100  (4.12) 
The rLOQ expresses the percentage fraction of the analyte which, upon addition to the 
biological sample that contains this analyte in the basal concentration C0,Ln, can be measured 
therein with acceptable accuracy [97]. 
Furthermore, it was proposed that LOQ and rLOQ be corrected, by the recovery values with 
which the LOQ values have been determined experimentally to become the recovery-corrected, 
LOQ,  LOQRec: 
LOQRec = 
rLOQ
𝑅𝑒𝑐@𝐶LOQ
     (4.13) 
Whereas Rec@CLOQ is the value of recovery with which the CLOQ is determined [97]. 
 
4.6 Range 
The range of an analytical method is defined as the interval between 2 concentration of analyte 
for which suitable precision, accuracy and linearity have been demonstrated. Thus, it is possible 
to differentiate between two types of range; working (analytical) range and linear (calibration) 
range.  
Analytical range describes the interval between the LOD and the highest concentration where 
the signal can be related to the concentration for the evaluation of random and systematic errors. 
The linear range corresponds to the valid functional interval where the dependence of the signal 
on concentration validated using the method of least square [95].  
In this thesis, LOD could not be defined since a blank sample was not available, and the linear 
dependence of the analyte signal on the concentration over the studied range (in Doelhert design 
experiments) was validated using the F-test, the reader is referred to section 3.1.6.  
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Table 4.2 shows the method linear range regarding both PGE2 and LTB4. 
 
Table 4.2 The validation parameters at each calibration points 
Analyte Endogenous 
concentration 
(ng/g) 
Calibration 
point 
number 
Number of 
replicates 
Concentration 
after analyte 
addition (ng/g) 
Concentration 
estimated 
(ng/g) 
Precision 
CV % 
Accuracy 
Rec % 
Rang 
ng/g 
PGE2 101.64 1 2 102.5 26.4 74 - 9181 1-50 
101-151 
2 3 126 12 52 - 302 
3 2 151 33.5 26 -136 
LTB4 86.67 1 2 88 258 10.5 701 1-50 
87 - 134 
2 3 111 238 60 15650 
3 2 136 52 30 -69 
 
It has been suggested for analytical methods, when determining the amount of an analyte in a 
biological sample, that the acceptable accuracy (recovery%) is 100±20% and precision (CV)  
≤20% [96.97]. Based on this, neither recovery nor precision values shown in table 4.2 are 
acceptable. Therefore rLOQ was not calculated. This might be because the concentration of IS 
used was 32.3 ng/g, which is not the optimum concentration for the quantification of LTB4 and 
PGE2. However, an optimum concentration of TLB4-d4 was used in two experimental points 
in the Doelhert design while unfortunately the optimum concentration of PGE2-d4 was never 
used in any experimental point since the only the Doelhert experimental were carried out, more 
experiments using the optimum concentration of internal standard need to carried out, 
unfortunately, time and salmon liver sample limitations did not allow preforming more 
experiments.    
Table 4.3 shows the validation parameters for the quantification of LTB4 when samples were 
spiked with 47.7 ng/g of internal standard. 
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Table 4.3.  The validation parameters when the optimum concentration of LTB4-d4 was added 
to samples 
 
Endogenous 
concentration 
(g/g) 
Number of 
replicates 
Concentration 
after analyte 
addition (ng/g) 
Concentration 
estimated 
(ng/g) 
Precision 
CV % 
Accuracy 
Rec % 
rLOQ 
% 
rLOQRec 
% 
86.67 2 98.9 97.42 20.6 98.4 15.5 16.7 
3 127.05 132.23 19.06 104     -    -  
 
4.7 Stability 
A loss in the target analyte might occur during the sample processing and storage, this might 
be because of different reasons (e.g. chemical degradation, adsorption on the test tube, etc.), 
thus, the stability of the analyte in solvent and sample extracts should be assessed [99]. 
The stability of PGE2 and LTB4 in the sample extract was assessed by storing samples extract 
in room temperature (+20 C°), fridge (+4 C°), and freezer (-80 C°), the samples were injected in 
the LC-MS for 3 consecutive days and the intensity of the target analytes compared to the 
intensity at day zero. 
Samples extracts were prepared from the same liver with the same procedure mentioned in 
section 3.2.2, and kept in disposable plastic tubes during storage. 
Before the injection samples were vacuum dried, diluted to 40 µL with acetonitrile then 
centrifuged at 6037×g for 1 min then injected in the LC-MS. Table 4.4 shows the relative target 
analyte EIC peak area obtained by MS in different days in samples stored in different conditions 
compared to the peak area of target analytes obtained by injecting the sample on the same day 
of preparation. 
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Table 4.4 Relative EIC peak areas for target analytes stored in different temperature over 
three days. 
 Storing temperature C° Relative peak area 
PGE2 % 
Relative peak area 
LTB4  % 
Day 1 -80 123 97 
+4 108 65 
+20 122 73 
Day 2 -80 188 97 
+4 113 63 
+20 107 93 
Day 3 -80 168 83 
+4 317 158 
+20 180 76 
   
It was noticed from Table 4.4 that there was no significant change in the MS signal for neither 
PGE2 and LTB4 after one day of storage in the -80 °C.  However, it was clear that the LTB4 
signal has decreased in the second and third storing day regardless of the storage temperature 
while the signal of PGE2 increased. 
The increase of the PGE2 signal could be explained by the formation of PGD2, PGD2 is known 
to be a stable isomer of PGE2. Also, PGD2 MS fragmentation products were reported to have 
similar m/z to those of PGE2 MS fragmentation [99], PGE2 formation might be caused by PGE2 
degradation.  
4.8 Conclusions and suggestions for further work 
The developed method exhibited good selectivity, linearity over the range (1-50) ng/g for both 
PGE2 and LTB4 respectively. In addition, the endogenous levels for PGE2 (87 ng/g) and LTB4 
(101 ng/g) indicate that the system linearity could be extended until 137 ng/g and 151 ng/g 
respectively. 
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The method precision for LTB4 quantification was found 19-20.6% and the recovery ranged 
between 98.4-104%, the relative limit of quantification rLOQ was found 15.5%. 
Both PGE2 and LTB4 were found stable at -80 °C for 24 hour after the extraction. 
In the present thesis the amount of available wild salmon liver was limited. For that reason, 
portion of the same liver were cut and processed for different kind of experiments. For example, 
the portions of liver were separated and submitted to the simplex design optimization, the 
Doehlert experiments and the stability studies.  It was reported that eicosanoids endogenous 
levels might differ within the same liver, hepatocyte produce a small amount of PGE2 
comparing to both kupffer and endothelial cells [5]. Consequently, it is important to submit the 
whole liver to the pulverization procedure proposed in the present thesis to ensure a high degree 
of sample homogeneity and a more uniform distribution of eicosanoids in the blank samples. 
Adding small glass pellets equivalent to the sample size (~0.3 g) to process the liver samples 
and using ultra sound water bath could improve the extraction of the analytical species. This 
suggestion was assessed by adding a volume of glass pellets and submitting the system to 
ultrasound after adding the extraction solvents. The final results revealed a clear and bright 
yellow oil system (Figure 4.2 A) that was not furtherly processed due to time restriction. 
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Figure 4.2 A. The oily phase remained after evaporating the extract, it was not able to inject in the 
LC/MS instrument. B. the extract after adding the (1:1) hexane methanol solution, the fatty phase was 
dissolved in the hexane phase.  
Perhaps, it would be advisable to add a mixture of methanol :hexane to separate the non polar 
components (Figure 4.2B). 
The concentration range of the internal standard proposed to be optimized was (15-50) ng/g, 
however, after considering the endogenous level of the analyte in the blank sample the range of 
the analyte concentration investigated was expanded to 150 ng/g and 137 ng/g for both PGE2 
and LTB4 respectively, thus the range of the internal standard should be extended to be between 
(75-125) ng/g, also method validation should be performed using the exact optimal amount of 
the internal standard. 
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Appendix 1. The Weight of samples used in Doelhert design experiments and the 
corresponding analyte and internal standard both real and theoretical concentration 
Sample 
number 
Weight 
(g) 
Corresponding 
experimental 
point in the 
Doelhert 
design 
Theoretical 
concentration 
ng/g 
Analyte real concentration 
                 ng/g 
            [A] [IS]         [A]         [IS] 
1 0.35 1          25.00 32.50 21.38 27.79 
2 0.28 1          25.00 32.50 26.28 34.19 
3 0.29 1          25.00 32.50 26.20 34.07 
4 0.33 2         13.20 17.30 33.52 15.57 
5 0.27 2         13.20 17.30 41.73 19.38 
6 0.30 3         50.00 47.70 13.40 48.43 
7 0.36 3          50.00 47.70 11.11 40.14 
8 0.35 4          13.20 17.30 11.18 14.65 
9 0.35 4          13.20 17.30 11.20 14.69 
10 0.28 4          13.20 17.30 14.17 18.58 
11 0.27 5          37.25 47.70 41.01 52.51 
12 0.29 5          37.25 47.70 38.64 49.48 
13 0.27 5          37.25 47.70 41.50 53.14 
14 0.34 6           1.00 32.50 0.87 28.39 
15 0.28 6           1.00 32.50 1.06 34.57 
16 0.29 7         50.00 32.50 51.44 33.44 
17 0.32 7         50.00 32.50 47.47 30.85 
18 0.30 8          0 17.30 0 16.91 
19 0.35 9          0 32.50 0 28.05 
20 0.33 9          0 32.50 0 29.58 
21 0.29 10          0 47.70 0 49.60 
 
 
